Transcranial Magnetic Stimulation and Potential Cortical and Trigeminothalamic Mechanisms in Migraine

Overview

Journal Brain

Publisher Oxford University Press

Specialty Neurology

Date 2016 Jun 2

PMID 27246325

Citations 40

Authors

Anna P Andreou

Philip R Holland

Simon Akerman

Oliver Summ

Joe Fredrick

Peter J Goadsby

Affiliations

Soon will be listed here.

Abstract

A single pulse of transcranial magnetic stimulation has been shown to be effective for the acute treatment of migraine with and without aura. Here we aimed to investigate the potential mechanisms of action of transcranial magnetic stimulation, using a transcortical approach, in preclinical migraine models. We tested the susceptibility of cortical spreading depression, the experimental correlate of migraine aura, and further evaluated the response of spontaneous and evoked trigeminovascular activity of second order trigemontothalamic and third order thalamocortical neurons in rats. Single pulse transcranial magnetic stimulation significantly inhibited both mechanical and chemically-induced cortical spreading depression when administered immediately post-induction in rats, but not when administered preinduction, and when controlled by a sham stimulation. Additionally transcranial magnetic stimulation significantly inhibited the spontaneous and evoked firing rate of third order thalamocortical projection neurons, but not second order neurons in the trigeminocervical complex, suggesting a potential modulatory effect that may underlie its utility in migraine. In gyrencephalic cat cortices, when administered post-cortical spreading depression, transcranial magnetic stimulation blocked the propagation of cortical spreading depression in two of eight animals. These results are the first to demonstrate that cortical spreading depression can be blocked in vivo using single pulse transcranial magnetic stimulation and further highlight a novel thalamocortical modulatory capacity that may explain the efficacy of magnetic stimulation in the treatment of migraine with and without aura.

Citing Articles

Update on Neuromodulation for Migraine and Other Primary Headache Disorders: Recent Advances and New Indications.

Cocores A, Smirnoff L, Greco G, Herrera R, Monteith T Curr Pain Headache Rep. 2025; 29(1):47.

PMID: 39954214 PMC: 11829934. DOI: 10.1007/s11916-024-01314-7.

The Mechanism of Acupuncture Therapy for Migraine: A Systematic Review of Animal Studies on Rats.

An Y, Zhang J, Ren Q, Liu J, Liu Z, Cao K J Pain Res. 2025; 18:473-487.

PMID: 39882184 PMC: 11776926. DOI: 10.2147/JPR.S504892.

Neuromodulation for Headache Management in Pregnancy.

Smirnoff L, Bravo M, Hyppolite T Curr Pain Headache Rep. 2025; 29(1):14.

PMID: 39777577 PMC: 11706918. DOI: 10.1007/s11916-024-01344-1.

Hallmarks of primary headache: part 1 - migraine.

Raggi A, Leonardi M, Arruda M, Caponnetto V, Castaldo M, Coppola G J Headache Pain. 2024; 25(1):189.

PMID: 39482575 PMC: 11529271. DOI: 10.1186/s10194-024-01889-x.

Efficacy and safety of high-frequency repetitive transcranial magnetic stimulation (rTMS) for migraine: a meta-analysis of randomized controlled trials.

Jiang Y, Yuan C, Sun P, Li C, Wang L Acta Neurol Belg. 2024; 124(4):1167-1176.

PMID: 38748342 DOI: 10.1007/s13760-024-02570-5.

References

Fregni F, Monte-Silva K, Oliveira M, Freedman S, Pascual-Leone A, Guedes R . Lasting accelerative effects of 1 Hz and 20 Hz electrical stimulation on cortical spreading depression: relevance for clinical applications of brain stimulation. Eur J Neurosci. 2005; 21(8):2278-84. DOI: 10.1111/j.1460-9568.2005.04064.x. View

Wu A, Fregni F, Simon D, Deblieck C, Pascual-Leone A . Noninvasive brain stimulation for Parkinson's disease and dystonia. Neurotherapeutics. 2008; 5(2):345-61. PMC: 3270324. DOI: 10.1016/j.nurt.2008.02.002. View

Burstein R, Jakubowski M, Garcia-Nicas E, Kainz V, Bajwa Z, Hargreaves R . Thalamic sensitization transforms localized pain into widespread allodynia. Ann Neurol. 2010; 68(1):81-91. PMC: 2930514. DOI: 10.1002/ana.21994. View

Akerman S, Holland P, Goadsby P . Diencephalic and brainstem mechanisms in migraine. Nat Rev Neurosci. 2011; 12(10):570-84. DOI: 10.1038/nrn3057. View

Andreou A, Shields K, Goadsby P . GABA and valproate modulate trigeminovascular nociceptive transmission in the thalamus. Neurobiol Dis. 2009; 37(2):314-23. DOI: 10.1016/j.nbd.2009.10.007. View

Ji R, Schlaepfer T, Aizenman C, Epstein C, Qiu D, Huang J . Repetitive transcranial magnetic stimulation activates specific regions in rat brain. Proc Natl Acad Sci U S A. 1998; 95(26):15635-40. PMC: 28096. DOI: 10.1073/pnas.95.26.15635. View

Navratilova E, Xie J, Meske D, Qu C, Morimura K, Okun A . Endogenous opioid activity in the anterior cingulate cortex is required for relief of pain. J Neurosci. 2015; 35(18):7264-71. PMC: 4420787. DOI: 10.1523/JNEUROSCI.3862-14.2015. View

Goadsby P, Charbit A, Andreou A, Akerman S, Holland P . Neurobiology of migraine. Neuroscience. 2009; 161(2):327-41. DOI: 10.1016/j.neuroscience.2009.03.019. View

Goadsby P, Lipton R, Ferrari M . Migraine--current understanding and treatment. N Engl J Med. 2002; 346(4):257-70. DOI: 10.1056/NEJMra010917. View

10.

Zhang X, Levy D, Kainz V, Noseda R, Jakubowski M, Burstein R . Activation of central trigeminovascular neurons by cortical spreading depression. Ann Neurol. 2011; 69(5):855-65. PMC: 3174689. DOI: 10.1002/ana.22329. View

11.

Pallanti S, Cantisani A, Grassi G, Antonini S, Cecchelli C, Burian J . rTMS age-dependent response in treatment-resistant depressed subjects: a mini-review. CNS Spectr. 2012; 17(1):24-30. DOI: 10.1017/S1092852912000417. View

12.

Afridi S, Goadsby P . Neuroimaging of migraine. Curr Pain Headache Rep. 2008; 10(3):221-4. DOI: 10.1007/s11916-006-0049-4. View

13.

Leone M, Franzini A, Bussone G . Stereotactic stimulation of posterior hypothalamic gray matter in a patient with intractable cluster headache. N Engl J Med. 2002; 345(19):1428-9. DOI: 10.1056/NEJM200111083451915. View

14.

Andreou A, Goadsby P . Topiramate in the treatment of migraine: a kainate (glutamate) receptor antagonist within the trigeminothalamic pathway. Cephalalgia. 2011; 31(13):1343-58. DOI: 10.1177/0333102411418259. View

15.

Summ O, Charbit A, Andreou A, Goadsby P . Modulation of nocioceptive transmission with calcitonin gene-related peptide receptor antagonists in the thalamus. Brain. 2010; 133(9):2540-8. DOI: 10.1093/brain/awq224. View

16.

Goadsby P, Sprenger T . Current practice and future directions in the prevention and acute management of migraine. Lancet Neurol. 2010; 9(3):285-98. DOI: 10.1016/S1474-4422(10)70005-3. View

17.

. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015; 386(9995):743-800. PMC: 4561509. DOI: 10.1016/S0140-6736(15)60692-4. View

18.

Rasmussen B, Olesen J . Migraine with aura and migraine without aura: an epidemiological study. Cephalalgia. 1992; 12(4):221-8; discussion 186. DOI: 10.1046/j.1468-2982.1992.1204221.x. View

19.

Holland P, Akerman S, Andreou A, Karsan N, Wemmie J, Goadsby P . Acid-sensing ion channel 1: a novel therapeutic target for migraine with aura. Ann Neurol. 2012; 72(4):559-63. DOI: 10.1002/ana.23653. View

20.

Holland P, Akerman S, Goadsby P . Cortical spreading depression-associated cerebral blood flow changes induced by mechanical stimulation are modulated by AMPA and GABA receptors. Cephalalgia. 2010; 30(5):519-27. DOI: 10.1111/j.1468-2982.2009.02021.x. View